title: [A study of an immunosuppressive acidic protein (IAP) in patients with a bone tumor].
abstract: We evaluated an immunosuppressive acidic protein (IAP) as a tumor marker in cases of a tumor of the bone (benign, 21; primary malignant, 26; metastatic carcinoma, 12). The IAP positive rate of a primary malignant tumor of the bone was 60%, and the mean was 591 + 59.4 micrograms/ml. This rate of a benign tumor of the bone was 10%, and the mean was 382 +/- 31.3 micrograms/ml. IAP may represent a tumor marker in malignant tumors of the bone.
authors.affiliation: Dept. of Orthopedic Surgery, Kumamoto Univ. Med. School.
authors.forename: O
authors.initials: O
authors.lastname: Mori
authors.forename: K
authors.initials: K
authors.lastname: Yonemura
authors.forename: K
authors.initials: K
authors.lastname: Morisawa
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis*; D001859:Bone Neoplasms / Q000032:analysis*; D002812:Chondroma / Q000032:analysis*; D002813:Chondrosarcoma / Q000032:analysis*; D006801:Humans; D009363:Neoplasm Proteins / Q000032:analysis*; D012516:Osteosarcoma / Q000032:analysis*
chemical_list: D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins; C030193:immunosuppressive acidic protein